: Shares in pharma giant Roche rise as COVID-19 tests offset drug sales slump
Demand for healthcare giant Roche’s COVID-19 tests helped to offset a decline in the core drugs business, the company said on Wednesday, as it reported sales for the first quarter of 2021 and confirmed its outlook for the year......»»
Merck sees $2.1 billion hit to full-year sales from coronavirus pandemic
Merck & Co Inc warned of a $2.1 billion hit to its 2020 revenue on Tuesday as social distancing due to the COVID-19 pandemic is expected to hammer sales of medically administered drugs including its blockbuster Keytruda treatment......»»
Wells Fargo close to roughly $3 billion settlement that would end probes into sales practices
Brendan McDermid/Reuters Wells Fargo is nearing a deal with federal prosecutors that would settle a years-long investigation into the bank's sales practices in its banking, auto lending, and mortgage divisions, The New York Times reported. .....»»
Twitter sales hit $1 billion for the first time
Twitter pulled in $1 billion in quarterly revenue for the first time, beating expectations for sales and new subscribers as efforts to make its platform more user-friendly paid off. Conway G. Gittens looks at the numbers......»»
Twitter sales hit $1 billion for the first time
Twitter pulled in $1 billion in quarterly revenue for the first time, beating expectations for sales and new subscribers as efforts to make its platform more user-friendly paid off. Conway G. Gittens looks at the numbers......»»
Roche and Gilead Losing Patent Protection on Top Sellers
Seven pharma companies face generic competition for medications that generated high U.S. sales in 2018Related Stocks: RHHBY, GILD, PFE, AMGN, GSK, INDV,.....»»
Black Friday pulls in a record $7.4 billion in online sales
Black Friday pulled in $7.4 billion and Small Business Saturday is set to make more. Adobe Analytics predicts Cyber Monday will be even bigger......»»
Black Friday pulls in a record $7.4 billion in online sales, as many turn to mobile orders
Black Friday pulled in $7.4 billion and Small Business Saturday is set to make more. Adobe Analytics predicts Cyber Monday will be even bigger......»»
Black Friday shoppers stay away from stores, make $7 billion-plus splurge online
U.S. shoppers made more purchases online on Black Friday than in the mall - hurting traffic and sales at brick-and-mortar stores, according to data that offered a glimpse into what is still one of the busiest shopping days of the year......»»
Amgen third-quarter revenue falls 3%, biosimilar sales rise
Amgen Inc on Tuesday said competition for older off-patent drugs sent third-quarter revenue down 3%, but share repurchases and biosimilar sales helped it achieve higher-than-expected profit, and the company raised its full-year outlook......»»
FTC staff recommends approval of Roche deal for Spark: report
The Federal Trade Commission staff reviewing Roche's plan to buy U.S.-based gene therapy specialist Spark Therapeutics for $4.3 billion recommended that the deal be approved without requiring any asset sales, the Capitol Forum reported on Thursday......»»
J&J bumps up full-year profit view on strength of cancer drugs
Johnson & Johnson on Tuesday boosted its full-year adjusted profit forecast, as multi-billion dollar sales of its cancer drugs Darzalex and Imbruvica helped it beat estimates for third-quarter profit......»»
Johnson & Johnson ordered to pay Pennsylvania man $8 billion over claims he wasn"t warned antipsychotic drug could make him grow breasts
Mario Tama/Getty Images A man has won $8 billion in punitive damages from Johnson & Johnson over claims that antipsychotic drugs gave him breasts without warning. Nicholas Murray, 26 was giv.....»»
Roche CEO touts drugs pipeline, rules out M&A just to boost sales
Swiss drugmaker Roche sees medicines in its own pipeline driving sales growth over the longer term, Chief Executive Severin Schwan told Reuters on Friday, adding he will not pursue takeovers simply to keep revenue rising......»»
Roche doesn"t need M&A to boost sales, sees growth from own meds: CEO
Swiss drugmaker Roche sees sales rising in the longer term from medicines in its own pipeline, Chief Executive Severin Schwan told Reuters on Friday, adding he does not want or need to do takeovers to mitigate looming patent losses......»»
Amgen results beat estimates, lung cancer trial planned
Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts......»»
Amgen results beat estimates, cancer drug shows wider activity
Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts......»»
Amgen quarterly results beat estimates, but revenue dips 3%
Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts......»»
Will Patent Woes Boost Pharma Stock Megamergers Further?
With key drugs losing exclusivity, key drug makers are poised to face deep trouble since their sales are mostly dependent on a single drug. Want the latest recommendations from Zacks Investment Research? Today, you can download 7.....»»
AbbVie + Allergan: Where Are The Synergies?
AbbVie (ABBV) is on the hunt for their next big revenue driver as their patent for the world???s top-selling drug, Humira, is nearing its end. AbbVie just made a $63 billion deal to acquire Dublin-based Allergan (AGN) in an a.....»»